Advertisement
Screener

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Form ARS: Annual report to security holders

BRAINSTORM CELL THERAPEUTICS INC. Form ARS: Annual report to security holders

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-05-16: Form ARS; Period of report 2024-12-31; Description ARS; Document tm2513997d6_ars.pdf.
  • 2024-08-16: Form ARS; Period of report 2023-12-31; Description ARS; Document tm2421739d1_ars.pdf.
  • 2015-07-20: Form ARS; Period of report 2014-12-31; Description AUTO-GENERATED PAPER DOCUMENT; Document 9999999997-15-012665.paper.
  • 2014-07-28: Form ARS; Period of report 2013-12-31; Description AUTO-GENERATED PAPER DOCUMENT; Document 9999999997-14-012464.paper.
FiledFormPeriod of reportDescriptionDocument
2025-05-16ARS2024-12-31ARStm2513997d6_ars.pdf
2024-08-16ARS2023-12-31ARStm2421739d1_ars.pdf
2015-07-20ARS2014-12-31AUTO-GENERATED PAPER DOCUMENT9999999997-15-012665.paper
2014-07-28ARS2013-12-31AUTO-GENERATED PAPER DOCUMENT9999999997-14-012464.paper
2013-03-26ARS2012-12-31AUTO-GENERATED PAPER DOCUMENT9999999997-13-007073.paper
2012-05-11ARS2011-12-31AUTO-GENERATED PAPER DOCUMENT9999999997-12-009841.paper
2011-05-11ARS2010-12-31AUTO-GENERATED PAPER DOCUMENT9999999997-11-010327.paper
2010-05-05ARS2009-12-31AUTO-GENERATED PAPER DOCUMENT9999999997-10-011658.paper
2008-05-02ARS2007-12-31AUTO-GENERATED PAPER DOCUMENT9999999997-08-024163.paper
2006-08-25ARS2006-03-31AUTO-GENERATED PAPER DOCUMENT9999999997-06-036752.paper

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
Pluri Inc. (PLUR)$0.014B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Passage BIO, Inc. (PASG)United States$0.015B-0.43
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37